# AimMax Therapeutics, Inc.: funding, NIH (2024)

Registers read on November 19, 2026.

AimMax Therapeutics, Inc. (North Carolina) appears in 2 public registers SpecStream reads: 1 Form D filing and 4 NIH and NSF awards; the newest record is dated April 1, 2024, and the registers were read on November 19, 2026.

SpecStream is the live web data engine for teams and agents. This page joins the public registers SpecStream already reads for one company.

- Registers: 2
- Newest record: April 1, 2024
- State: North Carolina

## Form D filings (SEC)

1 Form D filing, newest April 17, 2017.

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [Form D](https://specstream.ai/data/form-d/company/aimmax-therapeutics-inc-1701803) | April 17, 2017 | $200 thousand sold of $200 thousand offered; Other | [sec.gov](https://www.sec.gov/Archives/edgar/data/1701803/000170180317000001/0001701803-17-000001-index.htm) |

- [AimMax Therapeutics, Inc.](https://specstream.ai/data/form-d/company/aimmax-therapeutics-inc-1701803)
- [SEC EDGAR filings](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1701803&type=D)

## NIH and NSF research awards

4 NIH and NSF awards, newest April 1, 2024.

| Record | Date | Detail | Source |
| --- | --- | --- | --- |
| [NIH](https://specstream.ai/data/research-funding/organization/aimmax-therapeutics-inc-vcbngnmh78j9) | April 1, 2024 | A Single Dose Therapy to Treat Drug Resistant Gonorrhea; $306.5 thousand | [reporter.nih.gov](https://reporter.nih.gov/project-details/10919352) |
| [NIH](https://specstream.ai/data/research-funding/organization/aimmax-therapeutics-inc-vcbngnmh78j9) | May 4, 2023 | Development of a Novel Injectable Antibiotic to Treat Serious Multidrug-resistant Gram-positive Infections; $613.9 thousand | [reporter.nih.gov](https://reporter.nih.gov/project-details/10837145) |
| [NIH](https://specstream.ai/data/research-funding/organization/aimmax-therapeutics-inc-vcbngnmh78j9) | August 8, 2022 | Development of a Novel Oral Antibiotic for the Treatment of Drug Resistant Gonorrhea; $3.4 million | [reporter.nih.gov](https://reporter.nih.gov/project-details/11164501) |
| [NIH](https://specstream.ai/data/research-funding/organization/aimmax-therapeutics-inc-vcbngnmh78j9) | May 10, 2022 | Optimization and Characterization of Novel Antifungal Peptides; $612.9 thousand | [reporter.nih.gov](https://reporter.nih.gov/project-details/10620239) |

- [Aimmax Therapeutics, Inc.](https://specstream.ai/data/research-funding/organization/aimmax-therapeutics-inc-vcbngnmh78j9)

## How these records were matched

Records are joined when they carry the same SEC CIK, EIN or UEI, or when their legal names match word for word, legal form aside, at an address in the same state (North Carolina), and no register gives a second identifier, a second headquarters or a second filer of that name. Each record links to its own page and to the agency that published it.

Source: the registers named in each section. Public records of US federal and state agencies.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in North Carolina

- [Sports bars in North Carolina, United States](https://specstream.ai/data/businesses/sports-bars/north-carolina-united-states)
- [Nursing schools in North Carolina, United States](https://specstream.ai/data/businesses/nursing-schools/north-carolina-united-states)
- [Greek restaurants in North Carolina, United States](https://specstream.ai/data/businesses/greek-restaurants/north-carolina-united-states)
- [Colleges and universities in North Carolina, United States](https://specstream.ai/data/businesses/colleges-and-universities/north-carolina-united-states)
- [Window suppliers in North Carolina, United States](https://specstream.ai/data/businesses/window-suppliers/north-carolina-united-states)
- [Publishers in North Carolina, United States](https://specstream.ai/data/businesses/publishers/north-carolina-united-states)
